An Examination of the Policy Landscape for Personalized Medicine
Stephen J. Ubl, president and CEO of the Pharmaceutical Research and Manufacturers of America, will discuss the value and promise of personalized medicine at the 12th Annual State of Personalized Medicine Luncheon Address, including the fact that 25 percent of new drugs approved last year were so-called personalized medicine.